Published in Breast Cancer Res Treat on July 26, 2007
Targeting tumors with nanobodies for cancer imaging and therapy. J Control Release (2013) 1.04
EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells. Carcinogenesis (2006) 0.93
Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. J Control Release (2012) 0.81
Inhibition of tumor growth by targeted anti-EGFR/IGF-1R nanobullets depends on efficient blocking of cell survival pathways. Mol Pharm (2013) 0.81
Inhibiting the clathrin-mediated endocytosis pathway rescues K(IR)2.1 downregulation by pentamidine. Pflugers Arch (2012) 0.79
Analysis of EGF receptor oligomerization by homo-FRET. Methods Cell Biol (2013) 0.77